candesartan has been researched along with Ventricular Dysfunction in 3 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karnik, SS | 1 |
Unal, H | 1 |
Yasuda, N | 1 |
Akazawa, H | 1 |
Ito, K | 1 |
Shimizu, I | 1 |
Kudo-Sakamoto, Y | 1 |
Yabumoto, C | 1 |
Yano, M | 1 |
Yamamoto, R | 1 |
Ozasa, Y | 1 |
Minamino, T | 1 |
Naito, AT | 1 |
Oka, T | 1 |
Shiojima, I | 1 |
Tamura, K | 1 |
Umemura, S | 1 |
Paradis, P | 1 |
Nemer, M | 1 |
Komuro, I | 1 |
Hiura, N | 1 |
Wakatsuki, T | 1 |
Yamamoto, T | 1 |
Nishikado, A | 1 |
Oki, T | 1 |
Ito, S | 1 |
3 other studies available for candesartan and Ventricular Dysfunction
Article | Year |
---|---|
Angiotensin II receptor-induced cardiac remodeling in mice without angiotensin II.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Gene Expression Regulation; Male; Myocardium; Receptor, | 2012 |
Agonist-independent constitutive activity of angiotensin II receptor promotes cardiac remodeling in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, West | 2012 |
Effects of angiotensin II type 1 receptor antagonist (candesartan) in preventing fatal ventricular arrhythmias in dogs during acute myocardial ischemia and reperfusion.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Dogs; Heart Conductio | 2001 |